Lonza and Chr Hansen in Biotherapeutics JV

05.04.2019 - Swiss fine chemicals producer Lonza and Danish biosciences company Chr. Hansen are forming a 50:50 joint venture to develop and manufacture live biotherapeutic products (LBPs) for...